• Weight Loss Drug Belviq Pulled From Market Over ‘Slight' Cancer Risk

    13 days ago - By Time

    The maker of a weight loss drug pulled it from the market Thursday at the request of federal regulators, who said it posed a slight increased risk of cancer.
    Japan's Eisai Inc. said it was voluntarily withdrawing the drug, Belviq. (The company's U.S. headquarters is in Woodcliff Lake, New Jersey.) However, the company said in a statement that it disagreed with the U.S. Food and Drug Administration's interpretation of new data on the drug's safety and still believes Belviq's benefit outweighs the risk.
    The FDA said patients should stop taking Belviq immediately, dispose of leftover pills...
    Read more ...